Pharma Reviews: Industry blames policies, USFDA probes for 73% drop in pharma FDI

Industry representatives have attributed policies and USFDA investigations into the practices of certain Indian Pharma companies among the key ...
Read more: Industry blames policies, USFDA probes for 73% drop in pharma FDI